OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post COVID-19 irritable bowel syndrome
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 484-492
Open Access | Times Cited: 51
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 484-492
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis
Niloofar Seighali, Abolfazl Abdollahi, Arman Shafiee, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 51
Niloofar Seighali, Abolfazl Abdollahi, Arman Shafiee, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 51
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
Raphaela Iris Lau, Qi Su, I.S. Lau, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 256-265
Open Access | Times Cited: 50
Raphaela Iris Lau, Qi Su, I.S. Lau, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 256-265
Open Access | Times Cited: 50
Rome Foundation Working Team Report on overlap in disorders of gut–brain interaction
Giovanni Barbara, Imran Aziz, Sarah Ballou, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 2
Giovanni Barbara, Imran Aziz, Sarah Ballou, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 2
Meta‐analysis: Post‐COVID‐19 functional dyspepsia and irritable bowel syndrome
Giovanni Marasco, Marcello Maida, Cesare Cremon, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 1, pp. 6-15
Open Access | Times Cited: 34
Giovanni Marasco, Marcello Maida, Cesare Cremon, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 1, pp. 6-15
Open Access | Times Cited: 34
Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review
Vasile Valeriu Lupu, Cristina Mihaela Ghiciuc, Gabriela Ștefănescu, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 21, pp. 3241-3256
Open Access | Times Cited: 29
Vasile Valeriu Lupu, Cristina Mihaela Ghiciuc, Gabriela Ștefănescu, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 21, pp. 3241-3256
Open Access | Times Cited: 29
The gut microbiome in disorders of gut–brain interaction
Narjis Kraïmi, Taylor Ross, Julien Pujo, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Narjis Kraïmi, Taylor Ross, Julien Pujo, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes
Don L. Goldenberg
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152455-152455
Closed Access | Times Cited: 9
Don L. Goldenberg
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152455-152455
Closed Access | Times Cited: 9
Microbiota modulation in disorders of gut-brain interaction
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 12, pp. 1971-1979
Closed Access | Times Cited: 9
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 12, pp. 1971-1979
Closed Access | Times Cited: 9
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1431-1440
Closed Access | Times Cited: 9
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1431-1440
Closed Access | Times Cited: 9
Robust cross-cohort gut microbiome associations with COVID-19 severity
Junhui Li, Tarini Shankar Ghosh, Rachel MacCann, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Junhui Li, Tarini Shankar Ghosh, Rachel MacCann, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Post-infection functional gastrointestinal disorders following coronavirus disease-19: a prospective follow-up cohort study
Daya Zhang, Chen Chen, Yunqian Xie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Daya Zhang, Chen Chen, Yunqian Xie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach
Valeria Calcaterra, Sara Zanelli, Andrea Foppiani, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 95-95
Open Access | Times Cited: 7
Valeria Calcaterra, Sara Zanelli, Andrea Foppiani, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 95-95
Open Access | Times Cited: 7
Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management
Kit‐Leong Cheong, Shutong Chen, Bo Teng, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 860-860
Open Access | Times Cited: 14
Kit‐Leong Cheong, Shutong Chen, Bo Teng, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 860-860
Open Access | Times Cited: 14
Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells
Marianne El Khoury, Hassan Y. Naim
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Marianne El Khoury, Hassan Y. Naim
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Gastrointestinal manifestations of long COVID
Louise R King
Life Sciences (2024), pp. 123100-123100
Closed Access | Times Cited: 4
Louise R King
Life Sciences (2024), pp. 123100-123100
Closed Access | Times Cited: 4
Perspective Chapter: What Happens When You Don’t Recover from COVID-19?
Raj Kamal Choudhary
IntechOpen eBooks (2025)
Closed Access
Raj Kamal Choudhary
IntechOpen eBooks (2025)
Closed Access
Microbial Influences on Irritable Bowel Syndrome
Eamonn M.M. Quigley
Gastroenterology Clinics of North America (2025)
Closed Access
Eamonn M.M. Quigley
Gastroenterology Clinics of North America (2025)
Closed Access
Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection
Attilio Giacosa, Gaetan Claude Barrile, Clara Gasparri, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 723-723
Open Access
Attilio Giacosa, Gaetan Claude Barrile, Clara Gasparri, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 723-723
Open Access
Post‐COVID‐19 Disorders of Gut‐Brain Interaction: A New Challenge for Gastroenterologists
Mohamed G. Shiha, Imran Aziz
United European Gastroenterology Journal (2025)
Open Access
Mohamed G. Shiha, Imran Aziz
United European Gastroenterology Journal (2025)
Open Access
Trends in Prevalence of Rome IV Disorders of Gut‐Brain Interaction During the COVID‐19 Pandemic: Results From a Nationally Representative Sample of Over 160,000 People in the US
Christopher V. Almario, So Yung Choi, William D. Chey, et al.
Neurogastroenterology & Motility (2025)
Closed Access
Christopher V. Almario, So Yung Choi, William D. Chey, et al.
Neurogastroenterology & Motility (2025)
Closed Access
Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities
Giovanni Marasco, Keren Hod, Luigi Colecchia, et al.
United European Gastroenterology Journal (2025)
Open Access
Giovanni Marasco, Keren Hod, Luigi Colecchia, et al.
United European Gastroenterology Journal (2025)
Open Access
Post‐Acute Sequelae of COVID‐19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population‐Based Cohort Study
Tae Hyeon Kim, Yejun Son, Jaeyu Park, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Closed Access
Tae Hyeon Kim, Yejun Son, Jaeyu Park, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Closed Access
The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies
Ziyan Wang, Yinglong Peng, Minshan Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1865-1865
Open Access | Times Cited: 8
Ziyan Wang, Yinglong Peng, Minshan Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1865-1865
Open Access | Times Cited: 8
Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study
Sarah Ballou, Prashant Singh, Judy Nee, et al.
Gastroenterology (2023) Vol. 165, Iss. 3, pp. 647-655.e4
Open Access | Times Cited: 7
Sarah Ballou, Prashant Singh, Judy Nee, et al.
Gastroenterology (2023) Vol. 165, Iss. 3, pp. 647-655.e4
Open Access | Times Cited: 7
